Rosen AC - Search Results

1

Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic.

Rosen AC, Case EC, Dusza SW, Balagula Y, Gordon J, West DP, Lacouture ME. Rosen AC, et al. Am J Clin Dermatol. 2013 Aug;14(4):327-33. doi: 10.1007/s40257-013-0021-0. Am J Clin Dermatol. 2013. PMID: 23625802

2

Risk of rash in cancer patients treated with vandetanib: systematic review and meta-analysis.

Rosen AC, Wu S, Damse A, Sherman E, Lacouture ME. Rosen AC, et al. J Clin Endocrinol Metab. 2012 Apr;97(4):1125-33. doi: 10.1210/jc.2011-2677. Epub 2012 Feb 29. J Clin Endocrinol Metab. 2012. PMID: 22378813 Review.

3

Rash to the mTOR inhibitor everolimus: systematic review and meta-analysis.

Ramirez-Fort MK, Case EC, Rosen AC, Cerci FB, Wu S, Lacouture ME. Ramirez-Fort MK, et al. Among authors: rosen ac. Am J Clin Oncol. 2014 Jun;37(3):266-71. doi: 10.1097/COC.0b013e318277d62f. Am J Clin Oncol. 2014. PMID: 23241507 Review.

4

Pruritus in patients treated with targeted cancer therapies: systematic review and meta-analysis.

Ensslin CJ, Rosen AC, Wu S, Lacouture ME. Ensslin CJ, et al. Among authors: rosen ac. J Am Acad Dermatol. 2013 Nov;69(5):708-720. doi: 10.1016/j.jaad.2013.06.038. Epub 2013 Aug 24. J Am Acad Dermatol. 2013. PMID: 23981682 Free PMC article. Review.

5

Life-threatening dermatologic adverse events in oncology.

Rosen AC, Balagula Y, Raisch DW, Garg V, Nardone B, Larsen N, Sorrell J, West DP, Anadkat MJ, Lacouture ME. Rosen AC, et al. Anticancer Drugs. 2014 Feb;25(2):225-34. doi: 10.1097/CAD.0000000000000032. Anticancer Drugs. 2014. PMID: 24108082 Free PMC article.

6

Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors.

Balagula Y, Rosen A, Tan BH, Busam KJ, Pulitzer MP, Motzer RJ, Feldman DR, Konner JA, Reidy-Lagunes D, Myskowski PL, Lacouture ME. Balagula Y, et al. Cancer. 2012 Oct 15;118(20):5078-83. doi: 10.1002/cncr.27505. Epub 2012 Mar 21. Cancer. 2012. PMID: 22437824 Free article.

7

Characteristics of oral mucosal events related to bevacizumab treatment.

Gavrilovic IT, Balagula Y, Rosen AC, Ramaswamy V, Dickler MN, Dunkel IJ, Lacouture ME. Gavrilovic IT, et al. Among authors: rosen ac. Oncologist. 2012;17(2):274-8. doi: 10.1634/theoncologist.2011-0198. Epub 2012 Jan 26. Oncologist. 2012. PMID: 22282905 Free PMC article.

8

Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4.

Fischer A, Rosen AC, Ensslin CJ, Wu S, Lacouture ME. Fischer A, et al. Among authors: rosen ac. Dermatol Ther. 2013 Mar-Apr;26(2):135-48. doi: 10.1111/dth.12027. Dermatol Ther. 2013. PMID: 23551370 Review.

9

Clinico-morphological features of BRAF inhibition-induced proliferative skin lesions in cancer patients.

Belum VR, Rosen AC, Jaimes N, Dranitsaris G, Pulitzer MP, Busam KJ, Marghoob AA, Carvajal RD, Chapman PB, Lacouture ME. Belum VR, et al. Among authors: rosen ac. Cancer. 2015 Jan 1;121(1):60-8. doi: 10.1002/cncr.28980. Epub 2014 Sep 3. Cancer. 2015. PMID: 25186461 Free article.

10

Post-reconstruction dermatitis of the breast.

Rosen AC, Goh C, Lacouture ME, Mehrara BJ, Cordeiro PG, Myskowski PL. Rosen AC, et al. J Plast Reconstr Aesthet Surg. 2017 Oct;70(10):1369-1376. doi: 10.1016/j.bjps.2017.05.012. Epub 2017 May 20. J Plast Reconstr Aesthet Surg. 2017. PMID: 28602267 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters